These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9364682)

  • 41. Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.
    Iyer V; Cayatte C; Guzman B; Schneider-Ohrum K; Matuszak R; Snell A; Rajani GM; McCarthy MP; Muralidhara B
    Hum Vaccin Immunother; 2015; 11(7):1853-64. PubMed ID: 26090563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of water-in-oil-in-water multiple emulsion and microemulsion as potential adjuvants for immunization with rabies antigen.
    Leclercq SY; dos Santos RM; Macedo LB; Campos PC; Ferreira TC; de Almeida JG; Seniuk JG; Serakides R; Silva-Cunha A; Fialho SL
    Eur J Pharm Sci; 2011 Aug; 43(5):378-85. PubMed ID: 21627989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of fluorocarbon-in-water emulsions with added triglyceride.
    Weers JG; Arlauskas RA; Tarara TE; Pelura TJ
    Langmuir; 2004 Aug; 20(18):7430-5. PubMed ID: 15323486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants.
    Woodard LF; Jasman RL
    Vaccine; 1985 Jun; 3(2):137-44. PubMed ID: 4036272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
    Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin.
    Wabuke-Bunoti MA; Taku A; Fan DP; Kent S; Webster RG
    J Immunol; 1984 Oct; 133(4):2194-201. PubMed ID: 6206156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides.
    Mata E; Igartua M; Hernández RM; Rosas JE; Patarroyo ME; Pedraz JL
    Drug Deliv; 2010; 17(7):490-9. PubMed ID: 20500129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells.
    Lipford GB; Wagner H; Heeg K
    Vaccine; 1994 Jan; 12(1):73-80. PubMed ID: 8303944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.
    Schumacher R; Amacker M; Neuhaus D; Rosenthal R; Groeper C; Heberer M; Spagnoli GC; Zurbriggen R; Adamina M
    Vaccine; 2005 Dec; 23(48-49):5572-82. PubMed ID: 16165256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A solid-in-oil-in-water emulsion: An adjuvant-based immune-carrier enhances vaccine effect.
    Tahara Y; Mizuno R; Nishimura T; Mukai SA; Wakabayashi R; Kamiya N; Akiyoshi K; Goto M
    Biomaterials; 2022 Mar; 282():121385. PubMed ID: 35093824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control.
    Brewer KD; Weir GM; Dude I; Davis C; Parsons C; Penwell A; Rajagopalan R; Sammatur L; Bowen CV; Stanford MM
    J Biomed Sci; 2018 Jan; 25(1):7. PubMed ID: 29374458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.
    Audran R; Peter K; Dannull J; Men Y; Scandella E; Groettrup M; Gander B; Corradin G
    Vaccine; 2003 Mar; 21(11-12):1250-5. PubMed ID: 12559806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation.
    Babu JS; Nair S; Kanda P; Rouse BT
    Vaccine; 1995 Dec; 13(17):1669-76. PubMed ID: 8719518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemically administered gp100 encoding DNA vaccine for melanoma using water-in-oil-in-water multiple emulsion delivery systems.
    Kalariya M; Amiji MM
    Int J Pharm; 2013 Sep; 453(2):400-7. PubMed ID: 23702000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F; Gras-Masse H; Boutillon C; Chirat F; Deprez B; Guillet JG; Gomard E; Tartar A; Levy JP
    J Immunol; 1992 Nov; 149(10):3416-22. PubMed ID: 1385524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a Novel Spontaneous Emulsification Method for Peptide Delivery Using Porous Silica Particles.
    Toorisaka E; Nonaka Y
    J Oleo Sci; 2018 Mar; 67(3):303-306. PubMed ID: 29459516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.
    Varypataki EM; van der Maaden K; Bouwstra J; Ossendorp F; Jiskoot W
    AAPS J; 2015 Jan; 17(1):216-26. PubMed ID: 25387996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.
    Chen YF; Lin CW; Tsao YP; Chen SL
    J Virol; 2004 Feb; 78(3):1333-43. PubMed ID: 14722288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytotoxic T cell polyepitope vaccines delivered by ISCOMs.
    Le TT; Drane D; Malliaros J; Cox JC; Rothel L; Pearse M; Woodberry T; Gardner J; Suhrbier A
    Vaccine; 2001 Sep; 19(32):4669-75. PubMed ID: 11535315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Highly diverse T cell recognition of a single Plasmodium berghei peptide presented by a series of mutant H-2Kd molecules.
    Jaulin C; Casanova JL; Romero P; Luescher I; Cordey AS; Maryanski JL; Kourilsky P
    J Immunol; 1992 Dec; 149(12):3990-4. PubMed ID: 1281196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.